Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Coronavirus Report – Part 27: Pandemic Sees Clinical Trials for New Drugs Suspended, Postponed

Filed Under: Coronavirus, Pharma Tagged With: , , , , , , , , ,

Development of new drugs to treat diseases other than the novel coronavirus looks set to be delayed as the outbreak…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Coronavirus Report – Part 67: Pandemic Causes 75% Drop in Clinical Trials for Early April
Coronavirus Report – Part 67: Pandemic Causes 75% Drop in…
Coronavirus Report – Part 77: Japan’s Pharmaceutical Companies Move in Quick Order to Treat Infection
Coronavirus Report – Part 77: Japan’s Pharmaceutical…
Coronavirus Report – Part 24: Survey Reveals 12 Japanese Pharmaceutical Firms Working to Develop Cures
Coronavirus Report – Part 24: Survey Reveals 12 Japanese…
Coronavirus Report – Part 33: Japan Eyes Development of Five Potential Treatments
Coronavirus Report – Part 33: Japan Eyes Development of Five…
LSII to Launch Clinical Trials of Muse Cells to Treat Respiratory Failure in COVID-19 Patients
LSII to Launch Clinical Trials of Muse Cells to Treat…
Coronavirus Report – Part 58: Clinical Trials Begin for Slew of Potential Vaccines
Coronavirus Report – Part 58: Clinical Trials Begin for Slew…